EUVIMEDOpdag EUVIMED
Crossref

Point prevalence of epilepsy in dementia: A “real‐world” estimate

Antonella Muroni iD, Gianluca Floris, Giuseppe Borghero, Silvia Ardu, Maria Ida Pateri, Silvy Pilotto, Giada Pisano, Giovanni Defazio

Epileptic Disorders · 2024-04 · 26 (2) · 209-214

DOI: 10.1002/epd2.20199 ↗

At a glance

Journal article in Epileptic Disorders, published online on 2024-03-13. Written by Antonella Muroni and 7 co-authors. Institution: Institute of Neurology, Azienda Ospedaliero Universitaria di Cagliari, Cagliari, Italy. Major MEDLINE topics: Alzheimer Disease, Dementia, Dementia, Vascular, Epilepsy. Cited 6 times so far (Crossref); 30 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Objective

Several studies have demonstrated a higher frequency of seizures and epilepsy in Alzheimer's disease and other forms of dementia as compared with healthy elderly individuals. However, incidence and prevalence of epilepsy in the general population of dementia are unknown since most previous studies were performed in secondary‐tertiary referral centres. In addition, all prior studies but one provided “period” rather than “point” prevalence estimates.

Methods

We assessed point prevalence estimate of epileptic manifestations requiring antiepileptic medication in patients Alzheimer's disease, vascular dementia, and fronto‐temporal dementia from a secondary clinical setting.

Results

Point prevalence estimates were 6.4% (95% CI: 1.5 to 11.3) in Alzheimer's disease, 8.9% (95% CI: 1.4 to 16.4), in vascular dementia, and 6% (95% CI: 1.3 to 10.7) in fronto‐temporal dementia, rates that were greater than those observed in the healthy elderly population. Regardless of the etiology of dementia, epilepsy was characterized by unprovoked seizures that lacked distinguishing clinical features. Significance These findings support epilepsy as part of the spectrum of dementia. The similar point prevalence of definite epilepsy requiring AED treatment in Alzheimer's disease and non Alzheimer dementias raised the possibility of similar underlying mechanism of epileptogenesis. Although this was not a population‐based study, accurate point prevalence data from clinic setting would be important to better define the burden of epilepsy in dementia and the demands on health services to manage the condition.

Subjects

MeSH terms (MEDLINE)

Alzheimer DiseaseDementiaDementia, VascularEpilepsyHumansAgedPrevalenceSeizures

Author keywords

Epilepsyalzheimer's diseasefronto temporal dementiapoint prevalencevascular dementia

Authors and institutions

  • Institute of Neurology, Azienda Ospedaliero Universitaria di Cagliari, Cagliari, Italy.
  • Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
  • Department of Translational Biomedicine and Neurosciences, University of Bari "Aldo Moro", Bari, Italy.

ORCID profiles: Antonella Muroni

Cite

APA

Muroni, A., Floris, G., Borghero, G., Ardu, S., Pateri, M. I., Pilotto, S., Pisano, G., & Defazio, G. (2024). Point prevalence of epilepsy in dementia: A “real‐world” estimate. Epileptic Disorders, 26(2), 209-214. https://doi.org/10.1002/epd2.20199

Vancouver

Muroni A, Floris G, Borghero G, Ardu S, Pateri MI, Pilotto S, et al. Point prevalence of epilepsy in dementia: A “real‐world” estimate. Epileptic Disorders. 2024;26(2):209-214. doi:10.1002/epd2.20199

BibTeX
@article{Muroni2024,
  author = {Muroni, Antonella and Floris, Gianluca and Borghero, Giuseppe and Ardu, Silvia and Pateri, Maria Ida and Pilotto, Silvy and Pisano, Giada and Defazio, Giovanni},
  title = {Point prevalence of epilepsy in dementia: A “real‐world” estimate},
  journal = {Epileptic Disorders},
  year = {2024},
  volume = {26},
  number = {2},
  pages = {209--214},
  doi = {10.1002/epd2.20199}
}
Start for free →